AC137 amylin mimic data

AMLN presented data gathered in a Phase II pharmacokinetic study of the amylin mimic AC137 showing an unexpected dampening of glucose blood levels in diabetics after meals. AMLN found that

Read the full 303 word article

How to gain access

Continue reading with a
two-week free trial.